Pharmarise Holdings Corporation
PharmaRaise Holdings Co., Ltd. Matters Related to Controlling Shareholders, etc.
As a matter relating to controlling shareholders, Suzuken Co., Ltd. holds 20.1% of the company’s shares and the strategic business alliance is ongoing. Transactions via consolidated subsidiaries involve pharmaceutical purchases, with terms comparable to those with other business partners. The company maintains its independence in management decisions.
Key Figures
- Voting rights ownership: 20.1%
- Transaction amount: 11,635 million yen
- Shareholder: Suzuken Co., Ltd.
- Transaction period: June 1, Reiwa 7 – May 31, Reiwa 8
AI要約
Overview of Matters Related to Controlling Shareholders, etc.
This report discloses matters concerning the parent company, controlling shareholders, and other related parties, and clearly states that Suzuken Co., Ltd. owns 20.1% of our company's shares. The two companies have maintained a close cooperative relationship through the business capital alliance agreement signed on November 10, Reiwa 5. In addition, our group's consolidated subsidiaries procure pharmaceuticals, etc., from Suzuken's group, and there are currently no personnel connections. Management decisions and business execution are led by our company, ensuring independence.
Transactions and Amounts
Transactions with related parties by our company are considered none. For transactions between consolidated subsidiaries and related parties, during the period from June 1, Reiwa 7 to May 31, Reiwa 8, procurement of pharmaceuticals and other items was the main transaction, with transaction amounts reaching 11,635 million yen (accounts payable). Terms of these transactions are determined under the same conditions as transactions with unrelated counterparties with whom our subsidiaries have no relationship.
PharmaRaise Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
